![](https://www.ema.europa.eu/sites/default/files/styles/ema_smp_opengraph/public/2023-11/Web%20image_CHMP_standard_square.png.webp?itok=IknKx9RN)
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 27-30 January 2025
Eight new medicines recommended for approval EMA’s human medicines committee (CHMP) recommended eight medicines for approval at its January 2025 meeting. The CHMP recommended granting a marketing authorisation for Capvaxive (pneumococcal polysaccharide …